DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ocupress (Carteolol Hydrochloride Ophthalmic) - Published Studies

 
 



Ocupress Related Published Studies

Well-designed clinical trials related to Ocupress (Carteolol Ophthalmic)

[Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration]. [2010.11]

[Ocular hypotensive effect of 1% carteolol long-acting eye drops--a double-masked, randomized phase III study in ocular hypertension or primary open-angle glaucoma patients comparing long-acting carteolol eye drops vs. current product] [2007.06]

Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial. [2006.08]

Other research related to Ocupress (Carteolol Ophthalmic)

Time course of changes in ocular aberrations after instillation of carteolol long-acting solution and timolol gel-forming solution. [2011.04]

Simultaneous quantification of carteolol and dorzolamide in rabbit aqueous humor and ciliary body by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. [2010.03.15]

Effect of carteolol hydrochloride on 24-hour variation of intraocular pressure in normal-tension glaucoma. [2010.03]

[The influence of carteolol and pentoxyphylin on the visual field in glaucoma patients--case reports of selected patients] [2010.02]

[Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration]. [Article in Japanese] [2010]

Ocular carteolol: a review of its use in the management of glaucoma and ocular hypertension. [2007]

Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride. [2006.01]

Other possibly related research studies

Study of effects of antiglaucoma eye drops on N-methyl-D-aspartate-induced retinal damage. [2005.11]

[Toxic effects of medications on the cornea] [2007]

Effects of switching from topical beta-blockers to latanoprost on intraocular pressure in patients with normal-tension glaucoma. [2008.04]

Designing dendrimers for ocular drug delivery. [2010.01]

[Retrospective analysis of clinical characteristics of toxic anterior segment syndrome]. [2009.03]

Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers. [2009.11]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017